|Chemical and physical data|
|Molar mass||111.102 g/mol|
|3D model (JSmol)|
|(what is this?)|
Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.
- Amplimexon entry in the public domain NCI Dictionary of Cancer Terms
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|